Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 2/2010

Open Access 01-12-2010 | Original Paper

ASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group

Authors: Masahiro Jinzaki, Kakuya Kitagawa, I-Chen Tsai, Carmen Chan, Wei Yu, Hwan Seok Yong, Byoung Wook Choi, ASCI CCT & CMR Guideline Working Group

Published in: The International Journal of Cardiovascular Imaging | Special Issue 2/2010

Login to get access

Abstract

The use of contrast media for cardiac imaging becomes increasing as the widespread of cardiac CT and cardiac MR. A radiologist needs to carefully consider the indication and the injection protocol of contrast media to be used as well as the possibility of adverse effect. There are several guidelines for contrast media in western countries. However, these are focusing the adverse effect of contrast media. The Asian Society of Cardiovascular Imaging, the only society dedicated to cardiovascular imaging in Asia, formed a Working Group and created a guideline, which summarizes the integrated knowledge of contrast media for cardiac imaging. In cardiac imaging, coronary artery evaluation is feasible by non-contrast MR angiography, which can be an alternative examination in high risk patients for the use of iodine contrast media. Furthermore, the body habitus of Asian patients is usually smaller than that of their western counterparts. This necessitates modifications in the injection protocol and in the formula for calculation of estimated glomerular filtration rate. This guideline provided fundamental information for the use of contrast media for Asian patients in cardiac imaging.
Literature
3.
go back to reference Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992CrossRefPubMed Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992CrossRefPubMed
4.
go back to reference Ma Y, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944CrossRefPubMed Ma Y, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944CrossRefPubMed
5.
go back to reference Fleischmann D, Kamaya A (2009) Optimal vascular and parenchymal contrast enhancement: the current state of the art. Radiol Clin North Am 47(1):13–26CrossRefPubMed Fleischmann D, Kamaya A (2009) Optimal vascular and parenchymal contrast enhancement: the current state of the art. Radiol Clin North Am 47(1):13–26CrossRefPubMed
6.
go back to reference Bae KT, Heiken JP, Brink JA (1998) Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate–pharmacokinetic analysis and experimental porcine model. Radiology 206(2):455–464PubMed Bae KT, Heiken JP, Brink JA (1998) Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate–pharmacokinetic analysis and experimental porcine model. Radiology 206(2):455–464PubMed
7.
go back to reference Cademartiri F, van der Lugt A, Luccichenti G et al (2002) Parameters affecting bolus geometry in CTA: a review. J Comput Assist Tomogr 26(4):598–607CrossRefPubMed Cademartiri F, van der Lugt A, Luccichenti G et al (2002) Parameters affecting bolus geometry in CTA: a review. J Comput Assist Tomogr 26(4):598–607CrossRefPubMed
8.
go back to reference Becker CR, Hong C, Knez A et al (2003) Optimal contrast application for cardiac 4-detector-row computed tomography. Invest Radiol 38(11):690–694CrossRefPubMed Becker CR, Hong C, Knez A et al (2003) Optimal contrast application for cardiac 4-detector-row computed tomography. Invest Radiol 38(11):690–694CrossRefPubMed
9.
go back to reference Cademartiri F, Mollet NR, Lemos PA et al (2006) Higher intracoronary attenuation improves diagnostic accuracy in MDCT coronary angiography. AJR Am J Roentgenol 187(4):W430–W433CrossRefPubMed Cademartiri F, Mollet NR, Lemos PA et al (2006) Higher intracoronary attenuation improves diagnostic accuracy in MDCT coronary angiography. AJR Am J Roentgenol 187(4):W430–W433CrossRefPubMed
10.
go back to reference Cademartiri F, Maffei E, Palumbo AA et al (2008) Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography. Eur Radiol 18(3):576–583CrossRefPubMed Cademartiri F, Maffei E, Palumbo AA et al (2008) Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography. Eur Radiol 18(3):576–583CrossRefPubMed
11.
go back to reference Cademartiri F, Mollet NR, van der Lugt A et al (2005) Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation. Radiology 236(2):661–665CrossRefPubMed Cademartiri F, Mollet NR, van der Lugt A et al (2005) Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation. Radiology 236(2):661–665CrossRefPubMed
12.
go back to reference Rist C, Nikolaou K, Kirchin MA et al (2006) Contrast bolus optimization for cardiac 16-slice computed tomography: comparison of contrast medium formulations containing 300 and 400 milligrams of iodine per milliliter. Invest Radiol 41(5):460–467CrossRefPubMed Rist C, Nikolaou K, Kirchin MA et al (2006) Contrast bolus optimization for cardiac 16-slice computed tomography: comparison of contrast medium formulations containing 300 and 400 milligrams of iodine per milliliter. Invest Radiol 41(5):460–467CrossRefPubMed
13.
go back to reference Fleischmann D, Rubin GD, Bankier AA et al (2000) Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography. Radiology 214(2):363–371PubMed Fleischmann D, Rubin GD, Bankier AA et al (2000) Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography. Radiology 214(2):363–371PubMed
14.
go back to reference Haage P, Schmitz-Rode T, Hübner D et al (2000) Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax. AJR Am J Roentgenol 174(4):1049–1053PubMed Haage P, Schmitz-Rode T, Hübner D et al (2000) Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax. AJR Am J Roentgenol 174(4):1049–1053PubMed
15.
go back to reference Tatsugami F, Kanamoto T, Nakai G et al (2010) Reduction of the total injection volume of contrast material with a short injection duration in 64-detector row CT coronary angiography. Br J Radiol 83(985):35–39CrossRefPubMed Tatsugami F, Kanamoto T, Nakai G et al (2010) Reduction of the total injection volume of contrast material with a short injection duration in 64-detector row CT coronary angiography. Br J Radiol 83(985):35–39CrossRefPubMed
16.
go back to reference Tatsugami F, Matsuki M, Inada Y et al (2010) Feasibility of low-volume injections of contrast material with a body weight-adapted iodine-dose protocol in 320-detector row coronary CT angiography. Acad Radiol 17(2):207–211CrossRefPubMed Tatsugami F, Matsuki M, Inada Y et al (2010) Feasibility of low-volume injections of contrast material with a body weight-adapted iodine-dose protocol in 320-detector row coronary CT angiography. Acad Radiol 17(2):207–211CrossRefPubMed
17.
go back to reference Mitsumori LM, Wang E, May JM et al (2010) Triphasic contrast bolus for whole-chest ECG-gated 64-MDCT of patients with nonspecific chest pain: evaluation of arterial enhancement and streak artifact. AJR Am J Roentgenol 194(3):W263–W271CrossRefPubMed Mitsumori LM, Wang E, May JM et al (2010) Triphasic contrast bolus for whole-chest ECG-gated 64-MDCT of patients with nonspecific chest pain: evaluation of arterial enhancement and streak artifact. AJR Am J Roentgenol 194(3):W263–W271CrossRefPubMed
18.
go back to reference Litmanovich D, Zamboni GA, Hauser TH et al (2008) ECG-gated chest CT angiography with 64-MDCT and tri-phasic IV contrast administration regimen in patients with acute non-specific chest pain. Eur Radiol 18(2):308–317CrossRefPubMed Litmanovich D, Zamboni GA, Hauser TH et al (2008) ECG-gated chest CT angiography with 64-MDCT and tri-phasic IV contrast administration regimen in patients with acute non-specific chest pain. Eur Radiol 18(2):308–317CrossRefPubMed
19.
go back to reference Lu JG, Lv B, Chen XB et al. (2009) What is the best contrast injection protocol for 64-row multi-detector cardiac computed tomography? Eur J Radiol [Epub ahead of print] Lu JG, Lv B, Chen XB et al. (2009) What is the best contrast injection protocol for 64-row multi-detector cardiac computed tomography? Eur J Radiol [Epub ahead of print]
20.
go back to reference Lee VS (2006) Cardiovascular MR imaging: physical principles to practical protocols. In: Lee VS (ed) Tissue characteristics and contrast agents: PD, T1 and T2, 1st edn. Lippincott Williams & Wilkins, Philadelphia, pp 42–50 Lee VS (2006) Cardiovascular MR imaging: physical principles to practical protocols. In: Lee VS (ed) Tissue characteristics and contrast agents: PD, T1 and T2, 1st edn. Lippincott Williams & Wilkins, Philadelphia, pp 42–50
21.
go back to reference Ishida M, Sakuma H, Murashima S et al (2009) Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data. J Magn Reson Imag 29(1):205–210CrossRef Ishida M, Sakuma H, Murashima S et al (2009) Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data. J Magn Reson Imag 29(1):205–210CrossRef
22.
go back to reference Webb JA, Thomsen HS, Morcos SK (2005) Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15(6):1234–1240CrossRefPubMed Webb JA, Thomsen HS, Morcos SK (2005) Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15(6):1234–1240CrossRefPubMed
23.
go back to reference Sakuma H, Ichikawa Y, Chino S et al (2006) Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 48(10):1946–1950CrossRefPubMed Sakuma H, Ichikawa Y, Chino S et al (2006) Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 48(10):1946–1950CrossRefPubMed
24.
go back to reference Yamaguchi K, Katayama H, Takashima T et al (1991) Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 178(2):363–367PubMed Yamaguchi K, Katayama H, Takashima T et al (1991) Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 178(2):363–367PubMed
25.
go back to reference Laroche D, Aimone-Gastin I, Dubois F et al (1998) Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 209(1):183–190PubMed Laroche D, Aimone-Gastin I, Dubois F et al (1998) Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 209(1):183–190PubMed
26.
go back to reference Hopper KD, Houts PS, TenHave TR et al (1994) The effect of informed consent on the level of anxiety in patients given i.v. contrast material. AJR Am J Roentgenol 162(3):531–535PubMed Hopper KD, Houts PS, TenHave TR et al (1994) The effect of informed consent on the level of anxiety in patients given i.v. contrast material. AJR Am J Roentgenol 162(3):531–535PubMed
27.
go back to reference Federle MP, Chang PJ, Confer S et al (1998) Frequency and effects of ionic and nonionic CT contrast media during rapid bolus injection. Radiology 206(3):637–640PubMed Federle MP, Chang PJ, Confer S et al (1998) Frequency and effects of ionic and nonionic CT contrast media during rapid bolus injection. Radiology 206(3):637–640PubMed
28.
go back to reference Jacobs JE, Birnbaum BA, Langlotz CP (1998) Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology 209(2):411–416PubMed Jacobs JE, Birnbaum BA, Langlotz CP (1998) Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology 209(2):411–416PubMed
29.
go back to reference Wang CL, Cohan RH, Ellis JH et al (2007) Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69, 657 intravenous injections. Radiology 243(1):80–87CrossRefPubMed Wang CL, Cohan RH, Ellis JH et al (2007) Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69, 657 intravenous injections. Radiology 243(1):80–87CrossRefPubMed
30.
go back to reference Caro JJ, Trindade E, McGregor M (1991) The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. AJR Am J Roentgenol 156(4):825–832PubMed Caro JJ, Trindade E, McGregor M (1991) The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. AJR Am J Roentgenol 156(4):825–832PubMed
31.
go back to reference Bush WH, Swanson DP (1991) Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol 157(6):1153–1161PubMed Bush WH, Swanson DP (1991) Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol 157(6):1153–1161PubMed
32.
go back to reference Dillman JR, Strouse PJ, Ellis JH et al (2007) Incidence and severity of acute allergic-like reactions to i.v nonionic iodinated contrast material in children. AJR Am J Roentgenol 188(6):1643–1647CrossRefPubMed Dillman JR, Strouse PJ, Ellis JH et al (2007) Incidence and severity of acute allergic-like reactions to i.v nonionic iodinated contrast material in children. AJR Am J Roentgenol 188(6):1643–1647CrossRefPubMed
33.
go back to reference Katayama H, Yamaguchi K, Kozuka T et al (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175(3):621–628PubMed Katayama H, Yamaguchi K, Kozuka T et al (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175(3):621–628PubMed
34.
go back to reference Cochran ST, Bomyea K, Sayre JW (2001) Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol 176(6):1385–1388PubMed Cochran ST, Bomyea K, Sayre JW (2001) Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol 176(6):1385–1388PubMed
35.
go back to reference Wang CL, Cohan RH, Ellis JH et al (2008) Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 191(2):409–415CrossRefPubMed Wang CL, Cohan RH, Ellis JH et al (2008) Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 191(2):409–415CrossRefPubMed
36.
go back to reference Nelson KL, Gifford LM, Lauber-Huber C et al (1995) Clinical safety of gadopentetate dimeglumine. Radiology 196(2):439–443PubMed Nelson KL, Gifford LM, Lauber-Huber C et al (1995) Clinical safety of gadopentetate dimeglumine. Radiology 196(2):439–443PubMed
37.
go back to reference Herborn CU, Honold E, Wolf M et al (2007) Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol 42(1):58–62CrossRefPubMed Herborn CU, Honold E, Wolf M et al (2007) Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol 42(1):58–62CrossRefPubMed
38.
go back to reference Bleicher AG, Kanal E (2008) Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. Am J Roentgenol 191(6):W307–W311CrossRef Bleicher AG, Kanal E (2008) Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. Am J Roentgenol 191(6):W307–W311CrossRef
39.
go back to reference Christiansen C, Pichler WJ, Skotland T (2000) Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 10(12):1965–1975CrossRefPubMed Christiansen C, Pichler WJ, Skotland T (2000) Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 10(12):1965–1975CrossRefPubMed
40.
go back to reference Berkseth RO, Kjellstrand CM (1984) Radiologic contrast-induced nephropathy. Med Clin North Am 68(2):351–370PubMed Berkseth RO, Kjellstrand CM (1984) Radiologic contrast-induced nephropathy. Med Clin North Am 68(2):351–370PubMed
41.
go back to reference Cruz C, Hricak H, Samhouri F et al (1986) Contrast media for angiography: effect on renal function. Radiology 158(1):109–112PubMed Cruz C, Hricak H, Samhouri F et al (1986) Contrast media for angiography: effect on renal function. Radiology 158(1):109–112PubMed
42.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41CrossRefPubMed Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41CrossRefPubMed
43.
go back to reference Hafez T (2007) Modification of diet in renal disease (MDRD) estimated glomerular filtration rate (eGFR) formula. Am J Cardiol 99(4):584CrossRefPubMed Hafez T (2007) Modification of diet in renal disease (MDRD) estimated glomerular filtration rate (eGFR) formula. Am J Cardiol 99(4):584CrossRefPubMed
44.
go back to reference Solomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331(21):1416–1420CrossRefPubMed Solomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331(21):1416–1420CrossRefPubMed
45.
go back to reference Solomon RJ, Natarajan MK, Doucet S et al (2007) Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115(25):3189–3196CrossRefPubMed Solomon RJ, Natarajan MK, Doucet S et al (2007) Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115(25):3189–3196CrossRefPubMed
46.
go back to reference Baker CS, Wragg A, Kumar S et al (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41(12):2114–2118CrossRefPubMed Baker CS, Wragg A, Kumar S et al (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41(12):2114–2118CrossRefPubMed
47.
go back to reference Ferrario F, Barone MT, Landoni G et al (2009) Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy–a randomized controlled study. Nephrol Dial Transpl 24(10):3103–3107CrossRef Ferrario F, Barone MT, Landoni G et al (2009) Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy–a randomized controlled study. Nephrol Dial Transpl 24(10):3103–3107CrossRef
48.
go back to reference Kanter MZ (2006) Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 63(19):1821–1827CrossRefPubMed Kanter MZ (2006) Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 63(19):1821–1827CrossRefPubMed
49.
go back to reference Schweiger MJ, Chambers CE, Davidson CJ et al (2007) Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 69(1):135–140CrossRefPubMed Schweiger MJ, Chambers CE, Davidson CJ et al (2007) Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 69(1):135–140CrossRefPubMed
50.
go back to reference Younathan CM, Kaude JV, Cook MD et al (1994) Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated with maintenance dialysis. AJR Am J Roentgenol 163(4):969–971PubMed Younathan CM, Kaude JV, Cook MD et al (1994) Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated with maintenance dialysis. AJR Am J Roentgenol 163(4):969–971PubMed
52.
go back to reference Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transpl 21(4):1104–1108CrossRef Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transpl 21(4):1104–1108CrossRef
53.
go back to reference Perazella MA (2009) Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 4(2):461–469CrossRefPubMed Perazella MA (2009) Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 4(2):461–469CrossRefPubMed
54.
go back to reference Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17(9):2359–2362CrossRefPubMed Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17(9):2359–2362CrossRefPubMed
55.
go back to reference Prince MR, Zhang H, Morris M et al (2008) Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248(3):807–816CrossRefPubMed Prince MR, Zhang H, Morris M et al (2008) Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248(3):807–816CrossRefPubMed
Metadata
Title
ASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group
Authors
Masahiro Jinzaki
Kakuya Kitagawa
I-Chen Tsai
Carmen Chan
Wei Yu
Hwan Seok Yong
Byoung Wook Choi
ASCI CCT & CMR Guideline Working Group
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue Special Issue 2/2010
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-010-9691-3

Other articles of this Special Issue 2/2010

The International Journal of Cardiovascular Imaging 2/2010 Go to the issue